Attached files
| file | filename |
|---|---|
| EX-5.1 - OPINION OF WYRICK ROBBINS YATES & PONTON, LLP - Citius Pharmaceuticals, Inc. | ea122508ex5-1_citiuspharma.htm |
| S-1 - REGISTRATION STATEMENT - Citius Pharmaceuticals, Inc. | ea122508-s1_citiuspharma.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 and related Prospectus of Citius Pharmaceuticals, Inc. of our report dated December 16, 2019, relating to the consolidated financial statements of Citius Pharmaceuticals, Inc., appearing in the Annual Report on Form 10-K for the year ended September 30, 2019.
We also consent to the reference to our Firm under the caption "Experts" in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
June 5, 2020